Hugh Bowen is an Investor at SOSV SF & NY (Fka IndieBio), whose known portfolio counts 20 companies.
Is Hugh Bowen a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Focus
- Alt ProteinBiomanufacturingBiotechClean EnergyDeepTechDiagnosticsDrug DiscoveryFoodTechGenomicsWetlab Infrastructure
Contacts
Affiliated funds' portfolios
Investor at SOSV SF & NY (Fka IndieBio), whose known portfolio counts 20 companies
- Hyivy Health
- Transition Metal Solutions
- Fermeate
- TippingPoint Biosciences
- Flair
- SEQUENTIAL
- Cocoon
- Cellens
- OncoPrecision
- Cauldron Ferm
- heXem bio
- Lingrove
- and 8 more
Investor Profile
Hugh Bowen is listed against sectors Climate, Food, Hardware and Healthcare, and focus areas Alt Protein, Biomanufacturing, Biotech and Clean Energy in the database.
Stage-wise, the deals at SOSV SF & NY (Fka IndieBio) cluster around Pre-Seed, Seed and Series A rounds.
What the affiliated firm has backed is the closest available signal on whether Hugh Bowen is worth approaching.
Colleagues at SOSV SF & NY (Fka IndieBio)
Showing 20 of 29
Ben Joffe
Senior Partner
Lisbon, Portugal
Sean O'Sullivan
Managing Partner, SOSV
New York, United States
Alan Clayton
Roaming Mentor
Kinsale, Ireland
Alexander Hall-Daniels
Principal
New York, United States
Cyril Ebersweiler
General Partner
Singapore
Shawn Broderick
Venture Partner
Newtonville, United States
Oscar Ramos
General Partner
Shanghai, China
Parikshit Sharma
Partner
San Francisco, United States
Stephen Chambers
General Partner
New York, United States
James Caffyn
Mentor
New York, United States
Darshil P.
Venture Capital
Pickering, Canada
Justin H.
Investor
New York, United States
Diana Kam
Mentor
Singapore
William Bao Bean
Venture Partner
Riyadh, Saudi Arabia
Bill Liao
General Partner
Cork, Ireland
Yuan-Ting M.
Head Of Africa Investments
Nairobi, Kenya
Steve McCann
General Partner
Ireland
Pae W
General Partner
United States
Kelly Kirkpatrick
Investor
Ireland
Alex Kopelyan
Senior Director
United States
Frequently asked questions
Who is Hugh Bowen?
Hugh Bowen is an accelerator partner and venture capital investor based in United Kingdom, listed as Investor at SOSV SF & NY (Fka IndieBio). The known portfolio of that firm counts 20 companies. That portfolio belongs to the firm, not to Hugh Bowen personally.
What does Hugh Bowen invest in?
Listed sectors include Climate, Food, Hardware and Healthcare; listed focus areas include Alt Protein, Biomanufacturing, Biotech and Clean Energy. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Hugh Bowen invest at?
SOSV SF & NY (Fka IndieBio) appears in Pre-Seed, Seed and Series A rounds across its known deals, and Hugh Bowen is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Hugh Bowen listed at?
Hugh Bowen is listed as Investor at SOSV SF & NY (Fka IndieBio). 29 other people in the database share a firm with Hugh Bowen.
How do I contact Hugh Bowen?
An email address, a phone number and a LinkedIn page are on file for Hugh Bowen. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 6 September 2026 · How this data is built · Report a correction or request removal